JP2023532985A5 - - Google Patents

Info

Publication number
JP2023532985A5
JP2023532985A5 JP2023500279A JP2023500279A JP2023532985A5 JP 2023532985 A5 JP2023532985 A5 JP 2023532985A5 JP 2023500279 A JP2023500279 A JP 2023500279A JP 2023500279 A JP2023500279 A JP 2023500279A JP 2023532985 A5 JP2023532985 A5 JP 2023532985A5
Authority
JP
Japan
Prior art keywords
alkyl
group
alkoxy
cycloalkyl
epilepsy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023500279A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532985A (ja
JP7824664B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040486 external-priority patent/WO2022010880A1/en
Publication of JP2023532985A publication Critical patent/JP2023532985A/ja
Publication of JP2023532985A5 publication Critical patent/JP2023532985A5/ja
Application granted granted Critical
Publication of JP7824664B2 publication Critical patent/JP7824664B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023500279A 2020-07-06 2021-07-06 Kcnt1阻害剤及び使用方法 Active JP7824664B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063048335P 2020-07-06 2020-07-06
US63/048,335 2020-07-06
PCT/US2021/040486 WO2022010880A1 (en) 2020-07-06 2021-07-06 Kcnt1 inhibitors and methods of use

Publications (3)

Publication Number Publication Date
JP2023532985A JP2023532985A (ja) 2023-08-01
JP2023532985A5 true JP2023532985A5 (cg-RX-API-DMAC10.html) 2024-07-11
JP7824664B2 JP7824664B2 (ja) 2026-03-05

Family

ID=79552679

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023500279A Active JP7824664B2 (ja) 2020-07-06 2021-07-06 Kcnt1阻害剤及び使用方法

Country Status (10)

Country Link
US (1) US20230219921A1 (cg-RX-API-DMAC10.html)
EP (1) EP4175624A4 (cg-RX-API-DMAC10.html)
JP (1) JP7824664B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230035608A (cg-RX-API-DMAC10.html)
CN (1) CN116075297A (cg-RX-API-DMAC10.html)
AU (1) AU2021305058A1 (cg-RX-API-DMAC10.html)
CA (1) CA3188825A1 (cg-RX-API-DMAC10.html)
IL (1) IL299700B2 (cg-RX-API-DMAC10.html)
MX (1) MX2023000360A (cg-RX-API-DMAC10.html)
WO (1) WO2022010880A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4446314A3 (en) * 2019-05-03 2025-03-12 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use
CN120817941A (zh) * 2019-05-03 2025-10-21 普拉克西斯精密药物股份有限公司 Kcnt1抑制剂和使用方法
EP4110317B1 (en) 2020-02-28 2025-11-19 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use
US11773088B2 (en) 2020-11-02 2023-10-03 Praxis Precision Medicines, Inc. KCNT1 inhibitors and methods of use
JP2025514140A (ja) * 2022-04-25 2025-05-02 プラクシス プレシジョン メディシンズ, インコーポレイテッド ピラゾールコアを含むkcnt1阻害剤及び使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127547D0 (en) * 2001-11-16 2002-01-09 Astrazeneca Ab Chemical compounds
US20050026968A1 (en) * 2003-07-14 2005-02-03 University Of Tennessee Research Foundation Heterocyclic amides with anti-tuberculosis activity
US20080269241A1 (en) * 2007-02-15 2008-10-30 Darin Allen Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
CN101711245B (zh) * 2007-07-19 2015-03-25 H.隆德贝克有限公司 5元杂环酰胺及相关的化合物
WO2019018119A1 (en) * 2017-07-18 2019-01-24 Pairnomix, Llc METHODS FOR TREATING EPILEPSY AND DISORDERS ASSOCIATED WITH KCNTI
CN113710318A (zh) * 2019-04-26 2021-11-26 H.隆德贝克有限公司 作为Kv3钾通道激活剂的芳基磺酰基噻吩甲酰胺和芳基磺酰基呋喃甲酰胺
EP4446314A3 (en) * 2019-05-03 2025-03-12 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use

Similar Documents

Publication Publication Date Title
JP2023518838A5 (cg-RX-API-DMAC10.html)
JP2023515576A5 (cg-RX-API-DMAC10.html)
US6765008B1 (en) Pyrrolopyrimidines as CRF antagonists
JP2022531388A5 (cg-RX-API-DMAC10.html)
RU2196139C2 (ru) 1,4,5-тризамещенные производные имидазола, способы их получения и фармацевтическая композиция на их основе
NZ259114A (en) Pyrazolopyrimidines and pharmaceutical compositions thereof
JPWO2020017587A5 (cg-RX-API-DMAC10.html)
JP2022502442A5 (cg-RX-API-DMAC10.html)
AU2019283921A1 (en) Indole carboxamide compounds useful as kinase inhibitors
JP2004107358A (ja) 新規置換イミダゾール化合物
RU2013150811A (ru) Ингибиторы идо
JP2013541495A5 (cg-RX-API-DMAC10.html)
RU2004116916A (ru) Производные 5,6-биарил-пиразин-2-амида в качестве антагонистов cb1
JP2012515166A5 (cg-RX-API-DMAC10.html)
JP2024523488A5 (cg-RX-API-DMAC10.html)
RU2006116885A (ru) Производные n-фенил(пиперидин-2-ил)метил-бензамида, способ получения указанных соединений и их применение в терапии
JP2007508358A5 (cg-RX-API-DMAC10.html)
JP2004534096A5 (cg-RX-API-DMAC10.html)
RU2015101532A (ru) Замещенные бициклические алкокси-пиразольные аналоги в качестве аллостерических модуляторов рецепторов mglur5
JP2011510004A (ja) タンパク質キナーゼ阻害剤及びその使用
RU2010119560A (ru) Замещенные n-фенилбипирролидинкарбоксамиды и их терапевтическое применение
JP2017522340A5 (cg-RX-API-DMAC10.html)
JP2008518900A5 (cg-RX-API-DMAC10.html)
RU2015101512A (ru) Замещенные бициклические алкокси-пиразольные аналоги в качестве аллостерических модуляторов рецепторов mglur5
JP2022534709A5 (cg-RX-API-DMAC10.html)